Company

Ben Vigoda

Ben Vigoda

Founder & CEO

Ben is the CEO and Founder of Gamalon. He was previously the co-founder and CEO of Lyric Semiconductor, the first microprocessor architectures for statistical machine learning, growing out of Ben’s PhD at MIT. Lyric was acquired by Analog Devices, and Lyric’s technology is deployed in leading smartphones and consumer electronics, medical devices, wireless base stations, and automobiles. He has authored over 120 patents and academic publications, and his work has been featured in the Wall Street Journal, New York Times, EE Times, Scientific American, Wired, TechCrunch, and other media.

Ben has been an Intel Student Fellow, Kavli Foundation/National Academy of Sciences Fellow, served on the DARPA Information Science and Technology (ISAT) steering committee, and has held research appointments at MIT, Hewlett Packard, Mitsubishi, and the Santa Fe Institute.  He also co-founded Design That Matters, a not-for-profit that for the past decade has helped solve engineering and design problems in underserved communities and has saved thousands of infant lives by developing low-cost, easy-to-use medical technology such as infant incubators, UV therapy, pulse oximeters, and IV drip systems that have been fielded in 20 countries.


Joel Bauman

VP Business Development

Matt Finn

Chief Financial Officer

Ilya Kaplun

VP Software Engineering

Glynnis Kearney

VP Product & Strategy

Bryan Sadowski

VP Customer Success

Peter Hoopes

VP Worldwide Sales

Investors

  • Intel Capital
  • 406 Ventures
  • Omidyar Technology Ventures
  • Boston Seed Capital
  • Rivas Capital
  • Felicis Ventures

Andy Bechtolsheim

Investor

Steve Blank

Steve Blank

Investor

Ivan Chong

Ivan Chong

Investor

Adam D’Angelo

Investor

Georges Harik

Georges Harik

Investor

Raymie Stata

Raymie Stata

Investor

Matthew Sutton

Investor

Gamalon’s Bayesian Program Synthesis platform has been developed in part with funding from DARPA (contract no. FA8750-14-C-0001) and IARPA (contract no. 2016-16032900007).

Advisors

David Blei

Scientific Advisor

Noah D. Goodman

Scientific Advisor

Roman Lubynsky

Roman Lubynsky

Advisor